These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19917966)

  • 21. Risk of recurrence in patients with pulmonary embolism: predictive role of D-dimer and of residual perfusion defects on lung scintigraphy.
    Poli D; Cenci C; Antonucci E; Grifoni E; Arcangeli C; Prisco D; Abbate R; Miniati M
    Thromb Haemost; 2013 Feb; 109(2):181-6. PubMed ID: 23196319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doppler ultrasound and D-dimer: friend or foe?
    Riopel C; Bounameaux H
    Hamostaseologie; 2012; 32(1):28-36. PubMed ID: 22252568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation.
    Kjellberg U; van Rooijen M; Bremme K; Hellgren M
    Thromb Res; 2014 Oct; 134(4):837-45. PubMed ID: 25135795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of the Triage D-dimer test for exclusion of venous thromboembolism in outpatients.
    Ghys T; Achtergael W; Verschraegen I; Leus B; Jochmans K
    Thromb Res; 2008; 121(6):735-41. PubMed ID: 17888501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of an age-adjusted D-dimer in the diagnosis of venous thromboembolism.
    Adams D; Welch JL; Kline JA
    Ann Emerg Med; 2014 Sep; 64(3):232-4. PubMed ID: 24439717
    [No Abstract]   [Full Text] [Related]  

  • 26. D-dimer testing and recurrent venous thromboembolism after unprovoked pulmonary embolism: A post-hoc analysis of the prolong extension study.
    Pengo V; Palareti G; Cosmi B; Legnani C; Tosetto A; Alatri A; Marzot F; Pegoraro C; Cucchini U; Iliceto S;
    Thromb Haemost; 2008 Oct; 100(4):718-21. PubMed ID: 18841301
    [No Abstract]   [Full Text] [Related]  

  • 27. [Does D-dimer help when blood coagulates?].
    Lassila R
    Duodecim; 1999; 115(24):2707-9. PubMed ID: 11979609
    [No Abstract]   [Full Text] [Related]  

  • 28. Poor performance of D-dimer in excluding venous thromboembolism among patients with lymphoma and leukemia.
    Qdaisat A; Soud RA; Wu CC; Rojas Hernandez CM; Li J; Meng QH; Abdel-Razeq H; Yeung SJ
    Haematologica; 2019 Jun; 104(6):e265-e268. PubMed ID: 30630988
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnosis of venous thromboembolism].
    Righini M; Le Gal G
    Rev Prat; 2015 Feb; 65(2):176-81. PubMed ID: 25939217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venous Malformation and Localized Intravascular Coagulopathy in Children.
    Hung JW; Leung MW; Liu CS; Fung DH; Poon WL; Yam FS; Leung YC; Chung KL; Tang PM; Chao NS; Liu KK
    Eur J Pediatr Surg; 2017 Apr; 27(2):181-184. PubMed ID: 27089461
    [No Abstract]   [Full Text] [Related]  

  • 31. The benefit of D-Dimer testing to decide on stopping anticoagulation after a first unprovoked VTE: a matter of sex or of test sensitivity?
    Czihal M; Reinecke H
    Vasa; 2015 Sep; 44(5):399. PubMed ID: 26317262
    [No Abstract]   [Full Text] [Related]  

  • 32. Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study.
    Legnani C; Palareti G; Cosmi B; Cini M; Tosetto A; Tripodi A;
    Haematologica; 2008 Jun; 93(6):900-7. PubMed ID: 18443269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia.
    Trofatter KF; Howell ML; Greenberg CS; Hage ML
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):435-40. PubMed ID: 2915868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D-dimer: An Overview of Hemostasis and Fibrinolysis, Assays, and Clinical Applications.
    Olson JD
    Adv Clin Chem; 2015; 69():1-46. PubMed ID: 25934358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-dimer levels to screen for venous thromboembolism in patients with fractures caused by high-energy injuries.
    Niikura T; Sakai Y; Lee SY; Iwakura T; Nishida K; Kuroda R; Kurosaka M
    J Orthop Sci; 2015 Jul; 20(4):682-8. PubMed ID: 25797331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products.
    Madoiwa S; Kitajima I; Ohmori T; Sakata Y; Mimuro J
    Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-Dimer and prothrombin fragment 1 + 2 in urine and plasma in patients with clinically suspected venous thromboembolism.
    Wexels F; Seljeflot I; Pripp AH; Dahl OE
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):396-400. PubMed ID: 26595215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of venous thromboembolism in patients with borderline quantitative D-dimer levels.
    Taira T; Taira BR; Carmen M; Chohan J; Singer AJ
    Am J Emerg Med; 2010 May; 28(4):450-3. PubMed ID: 20466224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the risk of recurrent venous thromboembolism. The Austrian study on recurrent venous thromboembolism (AUREC).
    Kyrle PA; Eischer L
    Hamostaseologie; 2013 Aug; 33(3):201-9. PubMed ID: 23712242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Venous malformations and coagulopathy].
    Hermans C; Dessomme B; Lambert C; Deneys V
    Ann Chir Plast Esthet; 2006; 51(4-5):388-93. PubMed ID: 17005308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.